DGAT and triglyceride synthesis: A new target for obesity treatment?

Citation
Hc. Chen et Rv. Farese, DGAT and triglyceride synthesis: A new target for obesity treatment?, TREND CARD, 10(5), 2000, pp. 188-192
Citations number
19
Categorie Soggetti
Cardiovascular & Hematology Research
Journal title
TRENDS IN CARDIOVASCULAR MEDICINE
ISSN journal
10501738 → ACNP
Volume
10
Issue
5
Year of publication
2000
Pages
188 - 192
Database
ISI
SICI code
1050-1738(200007)10:5<188:DATSAN>2.0.ZU;2-T
Abstract
Because triglycerides are considered essential for survival and their synth esis has been thought to occur through a single mechanism, inhibiting trigl yceride synthesis has been largely unexplored as a possible target for obes ity treatment. However; recent studies indicate that mice lacking acyl CoA: diacylglycerol acyltransferase (DGAT), a key enzyme in triglyceride synthes is, are viable and resistant to diet-induced obesity. Unexpectedly, this re sistance is caused by a mechanism involving increased energy expenditure. T hese findings suggest that inhibiting specific components of triglyceride s ynthesis, such as DGAT is feasible and may represent a novel approach to tr eating obesity. (C) 2001, Elsevier Science Inc. All rights reserved.